AJ201
Spinal and bulbar muscular atrophy (SBMA)
PreclinicalActive
Key Facts
Indication
Spinal and bulbar muscular atrophy (SBMA)
Phase
Preclinical
Status
Active
Company
About AnnJi Pharmaceutical
Taiwan biotech developing first‑in‑class small‑molecule therapies for neurology, immunology and fibrosis.
View full company profileTherapeutic Areas
Other Spinal and bulbar muscular atrophy (SBMA) Drugs
| Drug | Company | Phase |
|---|---|---|
| PRMT6 Inhibitor Discovery (with Agora, Variational AI) | Enamine | Discovery |